CHGCY(CHGCY)
CHGCY
No analyst ratings available
No analyst price targets available for CHGCY
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.38T | $1.60T |
| Low | $1.36T | $1.57T |
| High | $1.43T | $1.65T |
| EBITDA Avg | $639.69B | $739.88B |
| Low | $628.25B | $726.64B |
| High | $659.73B | $763.05B |
| EBIT Avg | $601.74B | $695.98B |
| Low | $590.98B | $683.53B |
| High | $620.59B | $717.78B |
| Net Income Avg | $490.74B | $628.75B |
| Low | $479.32B | $614.13B |
| High | $510.71B | $654.35B |
| EPS Avg | $149.09 | $191.03 |
| Low | $145.63 | $186.58 |
| High | $155.16 | $198.80 |
| Analysts (Rev / EPS) | 7 / 1 | 7 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $352.72B | $381.58B |
| Low | $343.89B | $372.02B |
| High | $361.58B | $391.16B |
| EBITDA Avg | $163.26B | $176.62B |
| Low | $159.17B | $172.20B |
| High | $167.36B | $181.05B |
| EBIT Avg | $153.58B | $166.14B |
| Low | $149.73B | $161.98B |
| High | $157.43B | $170.31B |
| Net Income Avg | — | — |
| Low | — | — |
| High | — | — |
| EPS Avg | — | — |
| Low | — | — |
| High | — | — |
| Analysts (Rev / EPS) | 3 / — | 3 / — |